Morning Market Losers
June 02, 2014 at 09:46 AM EDT
Puma Biotechnology (NYSE: PBYI) shares declined 18.47% to $62.31 after the company presented positive PB272 Phase II data at ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.